NGS-Based RNA-Sequencing Market Worth USD 4.2 Billion - Growth in Precision Medicine Industry

Author : BloggerDJ
Publish Date : 2021-04-22


NGS-Based RNA-Sequencing Market Worth USD 4.2 Billion - Growth in Precision Medicine Industry

This report aims to provide detailed insights into the NGS-based RNA-sequencing market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Key Factors Driving Market Growth:

Market growth is driven mainly by the advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; and rapid growth in precision medicine market.

Expected Revenue Growth:

The NGS-based RNA-sequencing industry size is projected to reach USD 4.2 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 20.0% during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=102977816

The expression profiling analysis segment accounted for the largest share of the NGS-based RNA-sequencing industry, by application, in 2018

Based on application, the NGS-Based RNA-Sequencing Market is segmented into expression profiling analysis, small RNA sequencing, De Novo transcriptome assembly, and variant calling & transcriptome epigenetics. In 2018, the expression profiling analysis segment accounted for the largest share of the RNA Sequencing Market. The dominant market position of this segment is attributed mainly to the increasing prevalence of metabolic disorders, multiple sclerosis, and other diseases. These factors will continue to propel the demand for expression profiling analysis to provide specific treatment options in the RNA Sequencing market during the forecast period.

Browse in-depth TOC on "NGS-Based RNA-Sequencing Market"

71 – Tables
22 – Figures
140 – Pages

The nanopore segment is expected to register the highest growth in the NGS-based RNA-sequencing market, by type, during the forecast period

Based on technology, the NGS-based RNA-sequencing industry is segmented into sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing. Nanopore sequencing technology registers the highest growth rate in the market as it is the only sequencing technology with direct RNA sequencing capabilities and facilitates sequencing of full-length RNA strands and modified RNA nucleotides using a simple library prep, without the need of conversion to double-stranded DNA.

North America dominated the NGS-based RNA-sequencing market

North America accounted for the largest share of RNA Sequencing market in 2018. The large share of this region is the growing prevalence of target diseases, government support through funds for genomics research, advancements in RNA-Seq products, increasing research on cancer & inherited rare diseases, and the strong presence of key players such as Illumina (US), Thermo Fisher (US), and Agilent Technologies (US) in this region.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=102977816

Key Players:

Illumina (US), Thermo Fischer Scientific (US) and Oxford Nanopore (UK), Agilent Technologies, Inc. (US), BGI (China), PerkinElmer Inc. (US), QIAGEN (Germany), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd (Switzerland), Takara Bio Inc. (Japan), GENEWIZ, Inc. (US), Hamilton Company (US), Macrogen (South Korea), Zymo Research (US), and Tecan Genomics, Inc. among others are the major players operating in the NGS-based RNA-sequencing market.

Illumina dominates the RNA sequencing market with its technologically advanced & innovative platforms and associated sequencing products. The company’s product portfolio includes a wide range of highly interconnected products, including sequencing, genotyping, gene expression, and molecular diagnostic products. Illumina also offers NGS-based RNA sequencing services which further strengthens its market position. Over the past three years, Illumina has launched several products in the market.

In this report, the global NGS-based RNA-sequencing market has been segmented based on product & service, technology, application, end user, and region.

By Product & Service

  • Sample Preparation Products
  • Sequencing Platforms & Consumables
  • Sequencing Services
  • Data Analysis, Storage, & Management

By Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Single-molecule Real-time Sequencing
  • Nanopore Sequencing

By Application

  • Expression Profiling Analysis
  • Small RNA Sequencing
  • De Novo Transcriptome Assembly
  • Variant Calling & Transcriptome Epigenetics

By End User

  • Research & Academia
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Recent Developments

  • In May 2019, BGI (China) and GenomiQa (Australia) signed a services agreement for whole-genome sequencing on BGI’s DNBseqTM sequencing technology platform. Under this agreement, genomiQa will utilize BGI’s ISO15189 accredited laboratory sequencing facilities.
  • In November 2018, Illumina (US) acquired Pacific Biosciences (US), one of the leading provider of sequencing systems. This helped Illumina strengthen its sequencing product portfolio.
  • In June 2017, Agilent Technologies (US) and Agendia (US) entered into an agreement to expand their relationship to include the development of Agendia’s RNA-Seq kit version into Agilent’s current product portfolio.

Key Questions Addressed in This Report

  • What are the various types of RNA platforms/sequencers, consumables, sample preparation kits, and services offered by the top market players for NGS-based RNA-sequencing in established & emerging regions?
  • Who are the major players offering NGS-based RNA-sequencers for specific technologies such as sequencing by synthesis, ion semiconductor sequencing, single molecular real-time sequencing, and nanopore sequencing in major geographies?
  • What revenue impact will platforms and consumables have in the market during the forecast period?
  • What is the adoption pattern for platforms and consumables and sequencing services across the globe?
  • Which regions are likely to show the highest revenue generation during the forecast period?



Category :business

 You can trust Dragons Eye Filming to assist you with your aerial photography needs. This includes i

You can trust Dragons Eye Filming to assist you with your aerial photography needs. This includes i

- There may be elements of the process you didnt think about. Dont worry though, they are the experts and they will help


A Practical Approach to Data Protection

A Practical Approach to Data Protection

- In todays world, there are a lot of people who looks towards the mainstream media to inform them about what is taking place in the world.


How to Run a Successful Text Message Marketing Campaign

How to Run a Successful Text Message Marketing Campaign

- Text message marketing is the ongoing process of communicating business news, sales, promotions or other relevant information to your


Healthcare Analytical Testing Services Market - Growing Demand In Pharmaceutical Industry

Healthcare Analytical Testing Services Market - Growing Demand In Pharmaceutical Industry

- Healthcare Analytical Testing Services Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.